高级检索
当前位置: 首页 > 详情页

The association between circulating docosahexaenoic acid and lung cancer: A Mendelian randomization study

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China [2]China-Japan Friendship Hospital, Yinghuadong Road, Beijing 100029, Chaoyang District, China [3]The First Affiliated Hospital of China Medical University, Shengyang, China [4]Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China [5]Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [6]Department of Joint Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou Guangdong, China [7]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China [8]Department of International Physical Examination Center, The First Affiliated Hospital of China Medical University, Shengyang, China
出处:
ISSN:

关键词: Docosahexaenoic acid Lung cancer Mendelian randomization

摘要:
Lung cancer is a malignant tumor with a high incidence, it is vital to identify modifiable and avoidable risk factors for primary prevention, which can significantly lower the risk of cancer by preventing exposure to hazards and altering risky behavior. Some observational studies suggest that an increase in docosahexaenoic acid (DHA) consumption can reduce lung cancer risk. However, interpretation of these observational findings is difficult due to residual confounding or reverse causality. To evaluate the link between DHA and lung cancer, we have undertaken this analysis to examine the causal association between DHA and the risk of lung cancer using a two-sample Mendelian randomization (MR) framework.We performed a two-sample MR analysis to evaluate the causal effect of plasma DHA levels on lung cancer risk. For the exposure data, we extracted genetic variants as instrumental variables (IVs) that are strongly associated with DHA from a large-scale genome-wide association study (GWAS). We obtained the corresponding effect estimates for IVs on the risk of lung cancer with 11,348 cases and 15,861 controls. Finally, we applied Mendelian randomization analysis to obtain preliminary MR results and performed sensitivity analyses to verify the robustness of our results.According to the primary MR estimates and further sensitivity analyses, a higher serum DHA level was associated with a higher risk of lung cancer [OR = 1.159, 95% CI (1.04-1.30), P = 0.01]. For lung adenocarcinoma, the results also showed a close correlation between the DHA level and lung adenocarcinoma [OR = 1.277, 95% CI (1.09-1.50), P = 0.003], but it was not statistically significant for squamous cell carcinoma [OR = 1.071, 95% CI (0.89-1.29), P = 0.467].Our study revealed that plasma DHA is positively associated with the risk of lung cancer overall, especially for lung adenocarcinoma. This study provides new information to develop dietary guidelines for primary lung cancer prevention.Copyright © 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 1 区 营养学
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 营养学
JCR分区:
出版当年[2020]版:
Q1 NUTRITION & DIETETICS
最新[2023]版:
Q1 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China [2]China-Japan Friendship Hospital, Yinghuadong Road, Beijing 100029, Chaoyang District, China
通讯作者:
通讯机构: [3]The First Affiliated Hospital of China Medical University, Shengyang, China [8]Department of International Physical Examination Center, The First Affiliated Hospital of China Medical University, Shengyang, China [*1]Department of International Physical Examination Center, The first Affiliated Hospital of China Medical University, Shengyang, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)